Human enterovirus-like particle vaccine development (2014–2016)
- Grant type:
- Sentinext Therapeutics
- Researchers:
-
-
Emeritus Professor
Australian Institute for Bioengineering and Nanotechnology
-
- Funded by:
- Sentinext Therapeutics
